Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Cell Harvesting Market by Type (Automated Cell Harvesters, Manual Cell Harvesters), Application (Biopharmaceutical, Stem Cell Research) - Global Forecast 2024-2030
... to reach USD 2.34 billion in 2024, at a CAGR 8.96% to reach USD 3.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Harvesting Market. It offers ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.48 billion in 2024, at a CAGR 9.49% to reach USD 28.49 billion by 2030. Global Biopharmaceutical Bioseparation Systems Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 621.39 million in 2024, at a CAGR 11.71% to reach USD 1,213.54 million by 2030. Global Biopharmaceuticals Manufacturing Consumables Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 81.32 billion in 2023 and expected to reach USD 95.65 billion in 2024, at a CAGR 18.10% to reach USD 260.65 billion by 2030. Global Biopharmaceutical CMO & CRO Market FPNV Positioning Matrix The ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Global Forecast 2024-2030
... 2023 and expected to reach USD 71.32 billion in 2024, at a CAGR 10.64% to reach USD 131.08 billion by 2030. Drug discovery consists of new medications being discovered by using a vast array of ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Global Forecast 2024-2030
... and expected to reach USD 1.59 billion in 2024, at a CAGR 5.61% to reach USD 2.21 billion by 2030. Global Pompe Disease Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Cell Culture Media Market by Product Type (Chemically Defined Media, Classical Media, Lysogeny Broth), Application (Biological Drug Discovery, Biopharmaceuticals, Cancer Research), End-User - Global Forecast 2024-2030
... USD 1.42 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 13.53% to reach USD 3.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Ulcerative Colitis Market by Drug (Anti-Inflammatory Drugs, Anti-TNF Biologics, Calcineurin Inhibitors), Disease (Fulminant Colitis, Left-Sided Colitis, Pancolitis or Universal Colitis), Route of Administration - Global Forecast 2024-2030
... USD 7.45 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 9.41% to reach USD 13.99 billion by 2030. Global Ulcerative Colitis Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030
... USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030. Global Upstream Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Global Forecast 2024-2030
... expected to reach USD 3.15 billion in 2024, at a CAGR 5.24% to reach USD 4.30 billion by 2030. Global Spine Biologics MarketSpine biologics refer to a category of medical products and treatments that utilize ... Read More
-
Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Global Forecast 2024-2030
... 6.54 billion in 2023 and expected to reach USD 7.30 billion in 2024, at a CAGR 11.79% to reach USD 14.28 billion by 2030. Global Biologics Contract Development Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Life Sciences BPO Market by Services (Contract Sales & Marketing Outsourcing, Medical Devices Outsourcing, Pharmaceutical Outsourcing), Application (Medical Devices, Pharmaceutical & Biopharmaceuticals) - Global Forecast 2024-2030
... USD 387.64 billion in 2023 and expected to reach USD 423.92 billion in 2024, at a CAGR 9.49% to reach USD 731.43 billion by 2030. Global Life Sciences BPO Market FPNV Positioning Matrix The FPNV ... Read More
-
Biotechnology Instrumentation Market by Product (Bioreactors, Centrifuges, Electrophoresis), End-User (Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), Government & Academic Institutes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 26.49 billion in 2024, at a CAGR 9.84% to reach USD 46.67 billion by 2030. Global Biotechnology Instrumentation Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2024-2030
... to reach USD 581.42 million in 2024, at a CAGR 11.54% to reach USD 1,121.04 million by 2030. Global Bioprocess Analyzers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess ... Read More
-
Vasculitis Treatment Market by Drug Type (Biologics, Corticosteroids, Immunosuppressants), Disease Type (Large Vessel Vasculitis, Small & Medium Vessel Vasculitis), Distribution Channel - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 202.92 million in 2024, at a CAGR 5.21% to reach USD 275.53 million by 2030. Global Vasculitis Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Protein Engineering Market by Type (Coagulation Factors, Colony-Stimulating Factors, Erythropoietins), Product & Service (Consumables, Instruments, Software & Services), Technology, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 10.21% to reach USD 7.49 billion by 2030. Global Protein Engineering Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
Research Assistance
